James Hackett
- Oncology top 5%
- Neutropenia and Cancer Infections 9
- Cancer Research top 5%
- Cancer Genomics and Diagnostics 3
- Breast Cancer Treatment Studies 3
- Genetics top 5%
- Blood disorders and treatments 5
- Hematology top 5%
- Acute Myeloid Leukemia Research 4
- Hematopoietic Stem Cell Transplantation 3
- Dermatology top 5%
-
- Molecular Biology Techniques and Applications 4
- Advanced biosensing and bioanalysis techniques 3
- Co-authors
- Frankie A. HolmesJoffre BakerJohn A. GlaspyBertrand C. LiangSteven ShakDrew WatsonLouis FehrenbacherCharles P. Quesenberry
- Cited by
- OncologyCancer ResearchGenetics
- Partner nations
- United StatesUnited KingdomAustralia
In The Last Decade
James Hackett
30 papers receiving 1.4k citations
Peers
Comparison fields: 5 of 90
- Oncology 946
- Cancer Research 425
- Genetics 497
- Hematology 195
- Dermatology 140
Countries citing papers authored by James Hackett
This map shows the geographic impact of James Hackett's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James Hackett with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James Hackett more than expected).
Fields of papers citing papers by James Hackett
This network shows the impact of papers produced by James Hackett. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James Hackett. The network helps show where James Hackett may publish in the future.
Co-authorship network
The 25 scholars most cited alongside James Hackett, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2022 | 3 | |
| 2 | 2017 | 1 | |
| 3 | 2015 | 26 | |
| 4 | 2010 | 2 | |
| 5 | 2009 | 21 | |
| 6 | 2008 | 65 | |
| 7 | Optimized RNA extraction and RT-PCR assays provide successful molecular analysis on a wide variety of archival fixed tissues | 2007 | 4 |
| 8 | 2007 | 42 | |
| 9 | 2007 | 107 | |
| 10 | Multiple GSTM gene family members are recurrence risk markers in breast cancer | 2006 | 1 |
| 11 | 2005 | 26 | |
| 12 | 2003 | 15 | |
| 13 | 2003 | 152 | |
| 14 | 2003 | 45 | |
| 15 | 2003 | 36 | |
| 16 | A combined analysis of two pivotal randomized trials of a single dose of pegfilgrastim per chemotherapy cycle and daily Filgrastim in patients with stage II-IV breast cancer. | 2003 | 87 |
| 17 | 2002 | 241 | |
| 18 | 1997 | 27 | |
| 19 | 1994 | 13 | |
| 20 | 1992 | 20 |
About James Hackett
James Hackett is a scholar working on Hematology, Oncology and Emergency Medicine, having authored 30 papers that have together received 1.4k indexed citations. Recurring topics across this work include Neutropenia and Cancer Infections (9 papers), Blood disorders and treatments (5 papers), Acute Myeloid Leukemia Research (4 papers), Molecular Biology Techniques and Applications (4 papers), Hematopoietic Stem Cell Transplantation (3 papers), Cancer Genomics and Diagnostics (3 papers), Advanced biosensing and bioanalysis techniques (3 papers) and Breast Cancer Treatment Studies (3 papers). The work is most often cited by research in Oncology (946 citations), Cancer Research (425 citations) and Genetics (497 citations). James Hackett has collaborated with scholars based in United States, United Kingdom and Australia. Frequent co-authors include Frankie A. Holmes, Joffre Baker, John A. Glaspy, Bertrand C. Liang, Steven Shak, Drew Watson, Louis Fehrenbacher, Charles P. Quesenberry, C. Alexander and Laurel A. Habel. Their work appears in journals such as Journal of Clinical Oncology, Blood, Cancer Research, British Journal of Haematology and Clinical Breast Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.